Vivek Ramaswamy has an estimated net worth of $1.52 Billion. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Axovant Sciences Ltd., and Strive, Inc..

2023 was Vivek Ramaswamy's most active year for acquiring shares with 5 total transactions. Vivek Ramaswamy's most active month to acquire stocks was the month of November. 2025 was Vivek Ramaswamy's most active year for disposing of shares, totalling 22 transactions. Vivek Ramaswamy's most active month to dispose stocks was the month of November. 2025 saw Vivek Ramaswamy paying a total of $94,763,326.24 for 20,748,350 shares, this is the most they've acquired in one year. In 2025 Vivek Ramaswamy cashed out on 34,527,408 shares for a total of $253,493,477.97, their largest year based on trade value.